Latest filing published 16 Mar 2010 for WATSON PHARMACEUTICALS INC, €26k.
No signal scores available.
Thomas R. Giordano discloses dealings in 2 companies, chiefly Watson Pharmaceuticals Inc and Andrx Corp /DE/. We count 15 filings; the first trade dates from 28 February 2006 and the latest from 14 March 2010.
On the market, this insider has only sold: 1 sale, €265k in total. Besides market trades, the filings include 11 share grants and 1 option exercise.
The latest filing, published on 16 March 2010, reports a share grant of €26k in Watson Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations